HAE Stock-Based Compensation
Haemonetics Corp · Stock-Based Compensation
HAE Stock-Based Compensation
Latest reported$33.83Mperiod ending
HAE TTM Stock-Based Comp ($0.00 → $33.83M)
TTM stock-based compensation
High-resolution chart · PNG
HAE stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 33,826,000 | |
| 33,827,000 | |
| 31,637,000 | |
| 32,052,000 | |
| 31,320,000 | |
| 29,636,000 | |
| 30,119,000 | |
| 29,122,000 | |
| 28,971,000 | |
| 28,332,000 | |
| 27,970,000 | |
| 28,244,000 | |
| 27,273,000 | |
| 25,583,000 | |
| 23,622,000 | |
| 22,586,000 | |
| 22,830,000 | |
| 24,359,000 | |
| 26,372,000 | |
| 26,204,000 | |
| 26,177,000 | |
| 25,516,000 | |
| 23,805,000 | |
| 22,843,000 | |
| 21,891,000 | |
| 20,454,000 | |
| 19,500,000 | |
| 18,957,000 | |
| 18,539,000 | |
| 17,188,000 | |
| 18,408,000 | |
| 16,787,000 | |
| 15,061,000 | |
| 13,025,000 | |
| 9,902,000 | |
| 9,114,000 | |
| 8,653,000 | |
| 9,150,000 | |
| 7,358,000 | |
| 7,301,000 | |
| 5,625,000 | |
| 6,949,000 | |
| 10,075,000 | |
| 11,040,000 | |
| 13,770,000 | |
| 14,095,000 | |
| 13,636,000 | |
| 13,603,000 | |
| 13,557,000 | |
| 13,081,000 | |
| 12,702,000 | |
| 12,371,000 | |
| 11,565,000 | |
| 10,969,000 | |
| 10,490,000 | |
| 9,599,000 | |
| 9,302,000 | |
| 9,286,000 | |
| 9,392,000 | |
| 11,422,000 | |
| 11,014,000 | |
| 10,810,000 | |
| 10,837,000 | |
| 9,364,000 | |
| 9,685,000 | |
| 10,267,000 | |
| 15,389,000 | |
| 12,806,000 | |
| 10,593,000 | |
| 10,181,000 | |
| 96,000 | |
| 96,000 | |
| 96,000 | |
| 0 | |
| 9,495,000 | |
| 9,495,000 | |
| 9,495,000 | |
| 10,251,000 | |
| 3,027,000 | |
| 3,027,000 | |
| 3,027,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |